Clinical Trial Update: Aspirin Twice a Day in Patients With Diabetes and Acute Coronary Syndrome [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating aspirin taken twice daily in patients with diabetes and acute coronary syndrome; the study status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease
• Coronary Syndrome
• Diabetes Mellitus
• Obesity

Drugs mentioned

• Aspirin (Aspirin)

Snippet

Sponsor: Assistance Publique - Hôpitaux de Paris | Conditions: Diabetes Mellitus, Acute Coronary Syndrome | Phase 4 | Status: COMPLETED